Bartholin’s Gland Carcinomas: A 20 plus-year experience from Queensland


Objective: To review the records of cases of Bartholin’s Gland Carcinoma referred to the Queensland Centre for Gynaecological Cancer (QCGC) between mid 1993 and mid 2012. Methods: Bartholin’s Gland Carcinoma case data from QCGC were reviewed and analysed using the computer software Statistical Package for the Social Sciences 11.0. Results: Of the 12 cases four died of their disease, seven are still alive and disease free and one is alive with recurrent disease. The mean age at diagnosis was 52.8 years. Time from onset of symptoms to diagnosis averaged 5.8 months. All diagnoses were confirmed histologically. Presenting symptoms included a lump and pain. The most common presenting complaint was a lump. Treatment included surgical excision, occasional biopsy followed by radiotherapy with or without chemotherapy. In some cases radiation and chemotherapy was followed by vulvectomy of various extent. Conclusions: Bartholin’s Gland Carcinoma is a rare condition with outcome dependent on duration of symptoms, including delay in diagnosis, cell-type, cellular differentiation and the International Federation of Gynecology and Obstetrics (FIGO) classification. A Bartholin’s gland mass in a woman aged 40 years or more should be considered malignant until a biopsy proves otherwise.The incidence of Bartholin’s Gland Carcinoma in Queensland is less than that reported elsewhere but a higher proportion of squamous cell carcinomas was found in this small series.

Share and Cite:

S. C. Jones, I. , Crandon, A. and Sanday, K. (2012) Bartholin’s Gland Carcinomas: A 20 plus-year experience from Queensland. Open Journal of Obstetrics and Gynecology, 2, 385-388. doi: 10.4236/ojog.2012.24079.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] Finan, M.A. and Barre, G. (2003) Bartholin’s gland carcinoma, malignant melanoma and other rare tumours of the vulva. Best Practice & Research Clinical Obstetrics & Gynaecology, 17, 609-633. doi:10.1016/S1521-6934(03)00039-7
[2] Ridley, C.M. (2009) The vulva. In: Neill, S. and Lewis, F., Eds., 3rd Edition, Wiley-Blackwell, Oxford, 190.
[3] Ridley, C.M. (2009) The vulva. In: Neill, S. and Lewis, F., Eds., 3rd Edition, Wiley-Blackwell, Oxford, 191.
[4] Liebeskind, A., Machnicki, S. and Blackmun, D. (2004) Case of the month. Applied Radiology, 33, 49-53.
[5] Lelle, R.J., Davis, K.P. and Roberts, J.A. (1994) Adenoid cystic carcinoma of Bartholin’s gland: The University of Michigan experience. International Journal of Gynecological Cancer, 4, 145-149. doi:10.1046/j.1525-1438.1994.04030145.x
[6] Khoury-Collado, F., Elliot, K.S., Lee, Y., Chen, P.C. and Abulafia, O. (2005) Merkel cell carcinoma of Bartholin’s gland. Gynecologic Oncology, 97, 928-931. doi:10.1016/j.ygyno.2004.12.064
[7] McCluggage, W.G., Aydin, N.E., Wong, N.A. and Cooper, K. (2009) Low-grade epithelial-myoepithelial carcinoma of bartholin’s gland: Report of 2 cases of a distinct neoplasm arising in the vulvovaginal region. International Journal of Gynecological Pathology, 28, 286-291. doi:10.1097/PGP.0b013e31818e1040
[8] Kyriazi, M.A., Carvounis, E.E., Kitsou, M., Arkadopoulos, N., Nicolaidou, E., Fotiou, S. and Smymiotis, V. (2010) Myoepithelial carcinoma of the vulva mimicking bartholin’s gland abscess in a pregnant woman: Case report and review of literature. International Journal of Gynecological Pathology, 29, 501-504. doi:10.1097/PGP.0b013e3181d81cdb
[9] Obermair, A., Roller, S., Crandon, A.J., Perrin, L. and Nicklin, J.L. (2001) Primary bartholin gland carcinoma: A report of seven cases. ANZJOG, 41, 78-81.
[10] Felix, J.C., Cote, R.J., Kramer, E.W., Saigo, P. and Goldman, G.H. (1993) Carcinomas of bartholin’s gland. American Journal of Pathology, 142, 925-933.
[11] Woida, F.M. and Ribeiro-Silva, A. (2007) Adenoid cystic carcinoma of the Bartholin Gland. Archives of Pathology & Laboratory Medicine, 131, 796-798.

Copyright © 2022 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.